Post 2024
-
Clinical Year in Review Series Begins by Tackling ARDS, Asthma, Health Equity, and More
The first session of the Clinical Year in Review series at the ATS 2024 International Conference summarized recent research concerning acute respiratory distress syndrome (ARDS), asthma, health equity, and lung cancer.
-
Clinical Year in Review II Highlights New Findings in COPD, Critical Care, and Tuberculosis
The Clinical Year in Review series continued at ATS 2024, recounting critical findings related to COPD, critical care medicine, global lung health data, and tuberculosis.
-
Clinical Year in Review III Recaps Impactful Studies on Multiple Lung Diseases
The third day of the Clinical Year in Review series at ATS 2024 in San Diego focused on impactful research regarding several distinct lung diseases, sepsis, and medical education strategies.
-
Final Clinical Year in Review Session Includes Insights into Tobacco Abstinence, Sleep Medicine
The final Clinical Year in Review at this year’s International Conference featured investigations in tobacco abstinence, extracorporeal membrane oxygenation (ECMO), pulmonary vascular disease, and sleep medicine.
-
MECOR Program Celebrates 30 Years of Empowering Lung Health Research Worldwide
The ATS MECOR Program celebrated the 30th anniversary of its mission to empower local scientists in low- and middle-income countries to address the burden of respiratory diseases through advanced research methods at ATS 2024.